FDA Inspection 1319250 — NeuroMetrix, Inc.
The FDA completed an inspection of NeuroMetrix, Inc. on May 27, 2026 in Rockaway, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Devices.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 27, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Rockaway, NJ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 23088 | ISO 13485:2016 Clause 7.1 | Records of risk management activities in product realization not maintained |
| 23114 | ISO 13485:2016 Clause 7.3.6 | Design and development verification not performed |
| 23216 | ISO 13485:2016 Clause 8.2.2 | Lack of documented justification for not investigating complaint(s) |
| 630 | 21 CFR 803.17 | Lack of Written MDR Procedures |